Option Care Health, Inc. offers infusion services at home and at alternative sites in the United States. The company is headquartered in Bannockburn, Illinois.
| Revenue (TTM) | $5.69B |
| Gross Profit (TTM) | $1.09B |
| EBITDA | $405.09M |
| Operating Margin | 5.90% |
| Return on Equity | 16.00% |
| Return on Assets | 6.17% |
| Revenue/Share (TTM) | $36.17 |
| Book Value | $8.41 |
| Price-to-Book | 2.91 |
| Price-to-Sales (TTM) | 0.64 |
| EV/Revenue | 0.832 |
| EV/EBITDA | 11.53 |
| Quarterly Earnings Growth (YoY) | 12.90% |
| Quarterly Revenue Growth (YoY) | 1.90% |
| Shares Outstanding | $149.78M |
| Float | $147.75M |
| % Insiders | 1.28% |
| % Institutions | 108.74% |
Volatility is currently contracting
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
BANNOCKBURN, Ill., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced that John Rademacher, CEO and Meenal Sethna, CFO, will participate in the following up coming investor conferences:
An aging population and growing telehealth and AI adoption support the Zacks Medical - Outpatient and Home Healthcare industry. DVA, LFST, OPCH and AVAH stand to benefit.
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Option Care (OPCH) or Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Option Care (OPCH) and The Pennant Group, Inc. (PNTG). But which of these two stocks offers value investors a better bang for their buck right now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Option Care Health, Inc. (OPCH) Q2 2026 Earnings Call Transcript
Option Care Health NASDAQ: OPCH reported second-quarter 2026 results that exceeded its internal expectations, with revenue, adjusted EBITDA and adjusted earnings per share all improving sequentially. The home and alternate-site infusion provider maintained its full-year revenue outlook while narrowing its adjusted EBITDA and EPS guidance ranges.
Option Care (OPCH) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.41 per share a year ago.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on OPCH and any ticker you trade — then tracks every position and per-strategy win rate.
